Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma
about
Molecular prognostic prediction in liver cirrhosisUsing Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases.Serotonin Activated Hepatic Stellate Cells Contribute to Sex Disparity in Hepatocellular Carcinoma.Systemic and intratumoral balances between monocytes/macrophages and lymphocytes predict prognosis in hepatocellular carcinoma patients after surgery.Suberoylanilide hydroxamic acid suppresses hepatic stellate cells activation by HMGB1 dependent reduction of NF-κB1.Tumour-activated liver stromal cells regulate myeloid-derived suppressor cells accumulation in the liver.Tumor regulation of the tissue environment in the liver.Tailored algorithms for hepatocellular carcinoma surveillance: Is one-size-fits-all strategy outdated?Progress in tumor-associated macrophage (TAM)-targeted therapeutics.Prognostic value of preoperative peripheral monocyte count in patients with hepatocellular carcinoma after liver transplantation.Hepatic stellate cells as key target in liver fibrosis.Alteration of liver glycopatterns during cirrhosis and tumor progression induced by HBV.Activation of liver stromal cells is associated with male-biased liver tumor initiation in xmrk and Myc transgenic zebrafish.Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Extracellular vesicles as therapeutic carriers of microRNAs for cholangiocarcinoma.Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.The Role of Cancer-Associated Fibroblasts and Fibrosis in Liver Cancer.HBV-DNA Load-Related Peritumoral Inflammation and ALBI Scores Predict HBV Associated Hepatocellular Carcinoma Prognosis after Curative ResectionImmune Gene Expression Profile in Hepatocellular Carcinoma and Surrounding Tissue Predicts Time to Tumor RecurrenceCarcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
P2860
Q26784251-7E47E244-C881-4942-AB98-FFE792BC6E58Q31138564-141A8930-C287-48E3-9F31-61B77359EE08Q33600418-DC9B3E04-D8BF-4595-B402-8B9F6DD91721Q37327632-7BA30A0C-3118-4293-98BD-9964E98609FFQ38820295-50AA66C0-DE6E-40DC-9733-1CA65AA4A851Q39064350-C6DA1581-52F9-4DC7-95B1-B428E76B6A7AQ39123136-44135C48-D5FC-44E0-B6DC-11924315107AQ39197775-7A2F9DAF-389A-47AF-94A2-A14D2EB8BC9BQ39267549-601E6B19-F7F9-4F47-B0BC-07BB4CBBB43AQ40121042-E7A75D47-2DF8-46A3-8E17-0508712C2E13Q40200602-3EE26175-B1FA-4E91-B3BB-A7F69D30AB7AQ40809520-7BE8B944-EFE3-4E22-938D-C514598C1B49Q41606121-DD39A0B4-45CF-4A2C-9F95-729594665AF2Q41921861-214FB6D2-2D63-479B-A196-19B592733647Q49237863-09A6A354-9377-40A4-97F7-60162525712CQ50127735-337665A7-7442-4678-B56E-737E2B382395Q50350640-6D529E68-8665-4C84-BFBD-A677F2A155D5Q57492763-14C593B0-03B3-41DD-88F1-E407C76AA7EBQ57494809-EE0FC43F-9311-4812-AAC2-493EF517CB3BQ57807125-F9F4A14A-D3B8-4D2E-8AD8-DA209397C65F
P2860
Hepatic stellate cell and monocyte interaction contributes to poor prognosis in hepatocellular carcinoma
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hepatic stellate cell and mono ...... is in hepatocellular carcinoma
@ast
Hepatic stellate cell and mono ...... is in hepatocellular carcinoma
@en
type
label
Hepatic stellate cell and mono ...... is in hepatocellular carcinoma
@ast
Hepatic stellate cell and mono ...... is in hepatocellular carcinoma
@en
prefLabel
Hepatic stellate cell and mono ...... is in hepatocellular carcinoma
@ast
Hepatic stellate cell and mono ...... is in hepatocellular carcinoma
@en
P2093
P2860
P356
P1433
P1476
Hepatic stellate cell and mono ...... is in hepatocellular carcinoma
@en
P2093
Anuradha Budhu
Atsushi Takai
Ji Hoon Kim
Ju-Seog Lee
Marshonna Forgues
Qinghai Ye
Tim F Greten
Tobias Eggert
Xin Wei Wang
P2860
P304
P356
10.1002/HEP.27822
P407
P50
P577
2015-04-28T00:00:00Z